Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men

Iranian Journal of Immunology

Volumn 6, Issue 1, 2009, Pages 40-48

  Khezri, Abdol Aziz ^a   Shirazi, Mehdi ^b   Ayatollahi, Seyyed Mohammad Taghi ^b   Lotfi, Mehrzad ^b   Askarian, Mehrdad ^b   Ariafar, Ali ^b   Afrasiabi, Mohammad Amin ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ELISA; Prostate; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIGITAL RECTAL EXAMINATION; HUMAN; IRAN; LOWER URINARY TRACT SYMPTOM; MALE; PREDICTIVE VALUE; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN DENSITY; PROSTATE VOLUME; RACE; REFERENCE VALUE; TRANSRECTAL ULTRASONOGRAPHY; UROGENITAL SYSTEM PARAMETERS; AGING; BLOOD; HEALTH; HISTOLOGY; MIDDLE AGED; PROSTATE;

AGED; AGING; HEALTH; HUMANS; IRAN; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; REFERENCE VALUES;

EID: 67650400521     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality.Part I{cyrillic, ukrainian}: international comparisons. BJU Int 2002; 90: 162-73.
2. Kehinde EO, Mojiminiyi OA, Sheikh M, Al-Awadi KA, Daar AS, Al-Hunayan A, et al. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men. BJU Int 2005; 96: 308-312.
3. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the pros- tate. J Urol 1991; 145: 907-23.
4. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. Age- specific reference ranges for serum prostate specific antigen in black men. N Engl J Med 1996; 335: 304-10.
5. Walsh PC. Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters. Ann Intern Med 1993; 119: 948-9.
6. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of multicenter clinical trial of 6630 men. J Urol 1994; 151: 1283-90.
7. Oesterling JE, Kumamoto Y, Tsukamoto T, Girman CJ, Guess HA, Masumori N, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 1995; 75: 347-53.
8. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery -what we have learned and where we are going. J Urol 1999; 162: 293-306.
9. Pruthi RS. The dynamics of prostate-specific antigen in benign and malignant diseases of the prostate. BJU Int 2000; 86: 652-8.
10. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a commu- nity-based population of healthy men. establishment of age-specific reference ranges. JAMA 1993; 270: 860-4.
11. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991; 145: 984-7.
12. Cole TJ. Fitting smoothed centile curves to reference data (with discussion).Journal of Royal Statistical Society, Series A, 1988; 151: 385-418.
13. Pan H, Cole T (2005): User's guide to LMS chartmaker. Medical Research Council/ UK.
14. Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR, et al. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran. Int J Urol 2007; 14: 406-11.
15. Mehrabi S, Ghafarian Shirazi HR, Rasti M. Normal Serum Prostate specific antigen levels in men in Yasuj province,Islamic Republic of Iran. East Mediterr Health J. 2007;13: 1190-4.
16. Collins GN, Lee RJ, McKelvie GB, Rogers AC, Hehir M. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993; 71: 445-50.
17. Lee SE, Kwak C, Park MS, Lee CH, Kang W, Oh SJ. Ethnic differences in the age-related distribution of serum prostate- specific antigen values: a study in a healthy Korean male population. Urology 2000; 56: 1007-10.
18. He D, Wang M, Chen X, Gao Z, He H, Zhau HE, et al. Ethnic differences in distribution of serum prostate- specific antigen: a study in a healthy Chinese male population. Urology 2004; 63: 722-6.
19. Wu TT, Huang JK. The clinical usefulness of prostate-specific antigen (PSA) level and age-specific PSA reference ranges for detecting prostate cancer in Chinese. Urol Int 2004; 72: 208-11.
20. Saw S, Aw TC. Age- related reference intervals for free and total prostate-specific antigen in a Singaporean population. Pa- thology 2000; 32: 245-9.
21. Henderson RJ, Eastham JA, Culkin DJ, Kattan MW, Whatley T, Mata J, et al. Prostate-specific antigen (PSA) and PSA den- sity: racial differences in men without prostate cancer. J Natl Cancer Inst 1997; 89: 134-8.
22. Ito K, Raaijmakers R, Roobol M, Wildhagen M, Yamanaka H, Schröder FH. Prostate carcinoma detection and increased pros- tate-specific antigen levels after 4 years in Dutch and Japanese males who have no evidence of disease at initial screening. Cancer 2005; 103: 242-50.
23. Jacobsen SJ, Klee GG, Lilja H, Wright GL Jr, Oesterling JE. Stability of serum prostate-specific antigen determination across laboratory, assay and storage time. Urology 1995; 45: 447-53.
24. Junker R, Brandt B, Zechel C, Assmann G. Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays. Clin Chem 1997; 43: 1588-94.
25. Akazaki K, Stemmerman GN. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst 1973; 50: 1137-44
26. Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 1977; 20: 680-8.